Literature DB >> 4137806

Letter: Rifampicin and cortisone replacement therapy.

D N Maisey, R C Brown, J L Day.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4137806     DOI： 10.1016/s0140-6736(74)91230-6

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

1.  Inadequate treatment causing fasting ketoacidosis in a patient with Addisonian crisis.

Authors:  N Sucunza; R Corcoy
Journal:  J Endocrinol Invest       Date:  2005-09       Impact factor: 4.256

Review 2.  Drug interactions that matter. A critical reappraisal.

Authors:  G T McInnes; M J Brodie
Journal:  Drugs       Date:  1988-07       Impact factor: 9.546

Review 3.  Clinically significant interactions with drugs used in the treatment of tuberculosis.

Authors:  W W Yew
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

4.  Time course of the changes in prednisolone pharmacokinetics after co-administration or discontinuation of rifampin.

Authors:  K H Lee; J G Shin; W S Chong; S Kim; J S Lee; I J Jang; S G Shin
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

Review 5.  Pharmacokinetic drug interactions with rifampicin.

Authors:  K Venkatesan
Journal:  Clin Pharmacokinet       Date:  1992-01       Impact factor: 6.447

Review 6.  Pharmacokinetic interactions with rifampicin : clinical relevance.

Authors:  Mikko Niemi; Janne T Backman; Martin F Fromm; Pertti J Neuvonen; Kari T Kivistö
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

7.  A case of variant angina exacerbated by administration of rifampicin.

Authors:  K Tsuchihashi; K Fukami; H Kishimoto; T Sumiyoshi; K Haze; M Saito; K Hiramori
Journal:  Heart Vessels       Date:  1987       Impact factor: 2.037
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.